Literature DB >> 6773630

Comparison of the effects of vitamin D metabolites on collagen synthesis and resportion of fetal rat bone in organ culture.

L G Raisz, B E Kream, M D Smith, H A Simmons.   

Abstract

We compared the effects of four vitamin D metabolites, 1 alpha,25 dihydroxy vitamin D3 (1 alpha,25(OH)2D3), 1 alpha hydroxy vitamin D3 (1 alpha OH D3), 25 hydroxy vitamin D3 (25 OH D3), and 24R,25 dihydroxy vitamin D (24R,25(OH)sD3) on resorption and collagen synthesis in fetal rat bone maintained in organ culture. Resorption was quantitated by measuring the release of previously incorporated 45Ca from long bone shafts of 19-day fetal rats, and collagen synthesis was assessed by measuring the incorporation of 3H-proline into collagenase digestible protein (CDP) in calvaria from 21-day fetal rats. All four compounds stimulated bone resorption and inhibited collagen synthesis, but 1 alpha,25(OH)2D3 was approximately 1000 times more potent in both organ culture systems. Although the differences were small among the other three compounds, the order of potency was 1 alpha OH d3 > 25 OH D3 greater than or equal to 24R,25(OH)2D3. These results suggest that the receptor for 1 alpha 25(OH)2D3 in both bone resorbing and bone forming cells has similar affinities for several vitamin D metabolites.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6773630     DOI: 10.1007/bf02408532

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  8 in total

1.  A specific high-affinity binding macromolecule for 1,25-dihydroxyvitamin D3 in fetal bone.

Authors:  B E Kream; M Jose; S Yamada; H F DeLuca
Journal:  Science       Date:  1977-09-09       Impact factor: 47.728

2.  Origin of 25-hydroxyvitamin D3 binding protein from tissue cytosol preparations.

Authors:  B E Kream; H F DeLuca; D M Moriarity; N C Kendrick; J G Ghazarian
Journal:  Arch Biochem Biophys       Date:  1979-01       Impact factor: 4.013

3.  Human serum binding protein for vitamin D and its metabolites. II. Specific, high affinity association with a protein in nucleated tissue.

Authors:  N E Cooke; J Walgate; J G Haddad
Journal:  J Biol Chem       Date:  1979-07-10       Impact factor: 5.157

4.  Hormonal control of bone collagen synthesis in vitro: inhibitory effect of 1-hydroxylated vitamin D metabolites.

Authors:  L G Raisz; D M Maina; S C Gworek; J W Dietrich; E M Canalis
Journal:  Endocrinology       Date:  1978-03       Impact factor: 4.736

5.  Bone resorbing activity of vitamin D metabolites and congeners in vitro: influence of hydroxyl substituents in the A ring.

Authors:  P H Stern; C L Trummel; H K Schnoes; H F Deluca
Journal:  Endocrinology       Date:  1975-12       Impact factor: 4.736

6.  Vitamin D metabolites and bone mineralization in man.

Authors:  P Bordier; H Rasmussen; P Marie; L Miravet; J Gueris; A Ryckwaert
Journal:  J Clin Endocrinol Metab       Date:  1978-02       Impact factor: 5.958

7.  Highly specific binding of 1,25-dihydroxycholecalciferol in bone cytosol.

Authors:  S C Manolagas; C M Taylor; D C Anderson
Journal:  J Endocrinol       Date:  1979-01       Impact factor: 4.286

8.  1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture.

Authors:  L G Raisz; C L Trummel; M F Holick; H F DeLuca
Journal:  Science       Date:  1972-02-18       Impact factor: 47.728

  8 in total
  30 in total

Review 1.  Modulation of bone calcium-binding sites regulates plasma calcium: an hypothesis.

Authors:  F Bronner; W D Stein
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

2.  Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria.

Authors:  J E Zerwekh; K Sakhaee; N A Breslau; F Gottschalk; C Y Pak
Journal:  Osteoporos Int       Date:  1992-05       Impact factor: 4.507

3.  Individual and combined effects of calciotropic hormones and growth factors on mineral metabolism in embryonic chick tibiae.

Authors:  C Duvos; A Scutt; H Mayer
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-06       Impact factor: 2.416

Review 4.  Bone disease and idiopathic hypercalciuria.

Authors:  Joseph E Zerwekh
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

5.  Expression of fibroblast growth factor 23, vitamin D receptor, and sclerostin in bone tissue from hypercalciuric stone formers.

Authors:  Viviane Barcellos Menon; Rosa Maria Affonso Moysés; Samirah Abreu Gomes; Aluizio Barbosa de Carvalho; Vanda Jorgetti; Ita Pfeferman Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 8.237

6.  Cell density-dependent vitamin D effects on calcium accumulation in rat osteogenic sarcoma cells (ROS 17/2).

Authors:  Y S Kim; S J Birge; L V Avioli; R Miller
Journal:  Calcif Tissue Int       Date:  1987-10       Impact factor: 4.333

7.  Relationship between Urinary Calcium and Bone Mineral Density in Patients with Calcium Nephrolithiasis.

Authors:  Khashayar Sakhaee; Naim M Maalouf; John Poindexter; Beverley Adams-Huet; Orson W Moe
Journal:  J Urol       Date:  2017-01-05       Impact factor: 7.450

8.  Effect of 24R,25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells.

Authors:  H Yamato; R Okazaki; T Ishii; E Ogata; T Sato; M Kumegawa; K Akaogi; N Taniguchi; T Matsumoto
Journal:  Calcif Tissue Int       Date:  1993-03       Impact factor: 4.333

9.  Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3.

Authors:  Z Bar-Shavit; S L Teitelbaum; P Reitsma; A Hall; L E Pegg; J Trial; A J Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  The effects of prostaglandin E2, parathyroid hormone, 1,25 dihydroxycholecalciferol, and cyclic nucleotide analogs on alkaline phosphatase activity in osteoblastic cells.

Authors:  M Kumegawa; E Ikeda; S Tanaka; T Haneji; T Yora; Y Sakagishi; N Minami; M Hiramatsu
Journal:  Calcif Tissue Int       Date:  1984-01       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.